|
MechanismTop II inhibitors |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
经肝动脉注射替拉扎明再行肝动脉栓塞(TATE)与KN046联合治疗晚期肝转移性结直肠癌(MSS/ pMMR)的IIA期临床试验
[Translation] Phase IIA clinical trial of transhepatic arterial injection of tirapazamine followed by transarterial embolization (TATE) combined with KN046 in the treatment of advanced hepatic metastatic colorectal cancer (MSS/ pMMR)
研究经肝动脉注射替拉扎明再行肝动脉栓塞(TATE)与KN046联合治疗晚期肝转移性结直肠癌MSS/pMMR的有效性和安全性
[Translation] To study the efficacy and safety of transhepatic arterial injection of tirapazamine followed by transarterial embolization (TATE) combined with KN046 in the treatment of advanced hepatic metastatic colorectal cancer MSS/pMMR
100 Clinical Results associated with Hangzhou Taibo Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Hangzhou Taibo Pharmaceutical Technology Co., Ltd.
100 Deals associated with Hangzhou Taibo Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Hangzhou Taibo Pharmaceutical Technology Co., Ltd.